期刊文献+

转化生长因子-β_1对心脏移植排斥反应中心肌细胞凋亡的影响 被引量:1

Effect of TGF-β_1 on apoptosis of myocardial cells in rats heart transplantation rejection
原文传递
导出
摘要 目的:探讨转化生长因子-β1(TGF-β1)对心脏移植排斥反应中心肌细胞凋亡的影响。方法:采用大鼠颈部心脏移植模型,随机分为3组:对照组、移植组、TGF-β1组,分别于术后第1、3、5、7天各取4只移植心脏,原位末端标记(TUNEL)法染色检测心肌细胞凋亡,以心肌细胞凋亡阳性细胞数占总心肌细胞数的百分比作为心肌细胞凋亡指数(AI)。用免疫组化方法观察Bcl-2、Bax的表达情况。结果:移植组心肌细胞于术后第1天即出现凋亡,第3天明显增加,第7天达高峰。TGF-β1组各时间点心肌细胞AI明显小于对应的移植组(均P<0.01)。与移植组相比,TGF-β1组心肌细胞Bax表达明显降低(P<0.01)。结论:TGF-β1对心脏移植排斥反应中心肌细胞凋亡有显著抑制作用,可能与其下调Bax表达,提高Bcl-2/Bax比值有关。 Objective:To study the effect of TGF-β1 on apoptosis of myocardium in rats heart transplantation rejection. Method:Cervical heterotopic heart transplantation rate model was set up. At 1st ,3 rd ,5 th and 7th day after transplantation , apoptosis index was evalulated by the percentage of mycardial cells with TUNEL positive staining and protein level expression of Bcl-2 and Bax were also measured by immunohistochemistry method. Resuit: The apoptotic myocardial cells were significantly increased at 3rd day and the peak was at 7th day after transplantation in the transplant group. Protein level expression of Bax in TGF-β1 group was significantly lower than that in transplant group (P〈0.01). Apoptosis indexes of mycardial cells in TGF-β1 group were found significantly lower than trarsplant group (P〈0.01). Conclusion; TGF-β1 may increase the ratio of Bcl-2/Bax and protect myocardial cells against apoptosis in rats heart transplantation rejection.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2007年第9期679-681,共3页 Journal of Clinical Cardiology
关键词 心脏移植 转化生长因子-Β1 移植物排斥 细胞凋亡 Heart transplantation Transforming growth factors-beta Graft rejection Apoptosis
  • 相关文献

参考文献17

  • 1CERWENKA A, SWAIN S L. TGF-betal: immunosuppressant and viability factor for T lympocytes[J] . Microbes Infect, 1999,1 : 1291 -- 1296.
  • 2PRUD G J, PICCIRILLO C A. The inhibitory effects of transforming growth factors-beta-1 (TGF-betal) in autoimmune diseases[J]. J Autoimmun, 2000,14 : 23-- 42.
  • 3SINGH N P, GUO L, MHOYAN A, et al. Predomi- nant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection[J]. Transplantation, 2003,75:586--590.
  • 4DONG C M, GRANVILLE D J, TUFFNEL C E, et al. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts[J]. Lab Invest, 1999, 79:1643 --1653.
  • 5YANG X C, MA N, SZABOLCS M J, et al. Upregulation of COX-2 during cardiac allograft rejection[J] Circulation, 2000,101 : 430-438.
  • 6KOGLIN J. Alloimmune-mediated apoptosis [ J ].Transplantation, 1999, 67 : 904 -- 909.
  • 7AWAD M R, WEBBER S, BOYLE G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome[J]. J Heart Lung Transplant, 2001,20:625 --630.
  • 8MICHAELS P J, KOBASHIGAWA J, LAKS H, et al. Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and quilty B lesions [J]. J Heart Lung Transplant, 2001, 20:407--416.
  • 9DENSEM C G, HUTCHINSON I V, COOPER A, et al. Polymorphism of the transforming growth fac- tor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation [J]. J Heart Lung Transplant, 2000, 19:551--556.
  • 10SHITTU E A, YANG C P, ROBERTS I S, et al. Inhibition of chronic vascular rejection by donor-specific blood transfusion is associated with a reduction in transforming growth factor-betal expression [J]. Transplantation ,2002,73 : 1573-- 1581.

二级参考文献10

  • 1[1]Piccotti J R, Li K, Chan S Y, et al. Interleukin-12 (IL-12)-driven alloimmune responses in vitro and in vivo: requirement for beta1 subunit of the IL-12 receptor . Transplantation, 1999 ,67:1453-1460.
  • 2[2]Smith X G, Bolton E M, Ruchatz H, et al. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol, 2000, 165:3444-3450.
  • 3[3]Tasaki K, Yoshida Y, Maeda T, et al. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells .Cancer Gene Ther,2000,7:247-254.
  • 4[4]Ito K, Takaishi H, Jin Y, Staphylococcal enterotoxion B stimulates expansion of autoreactive T cells that induceapoptosis in intestinal epithelial cells: Regulation of autoreactive response by IL-10. J Immunol,2000,164:2994-3001.
  • 5[5]Sambrook J, Fritsch E F, Maniatis T. 分子克隆学. 北京:科学出版社,1998.343-407.
  • 6[6]Hutchiuson I V, Pracica V, Perrey C, et al. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc, 1999,31:734-736.
  • 7[7]Wang H, DeVries M E, Deng S, et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med, 2000, 6:549-555.
  • 8[8]Baan C C, Knoop C J, Holweg C T, et al. The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation .Transplant Proc ,1999 ,31:2726-2728.
  • 9[9]Reddy P, Teshima T, Hildebrandt G, et al. Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood ,2002 ,100:3429-3431.
  • 10[10]Mulligan M S, Warner R L, McDuffie J E, et al. Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection. Exp Mol Pathol ,2000, 69:1-9.

同被引文献19

  • 1Abbate A,Biondi-Zoccai GG, Baldi A.Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling[J].J Cell Physiol, 2002,193 (2) : 145-153.
  • 2Abbat e A, Biondi-Zoccai GG, Bussani R, et al.Increased myocardial apoptosis in patients with unfavorable left ven- tricular remodeling and early symptomatic post-infarction heart failure[J].J Am Coll Cardiol, 2003,41 (5) : 753 -760.
  • 3Bakhshayesh M,Zaker F, Hashemi M,et al.TGF-betal - mediated apoptosis associated with SMAD-dependent mi- tochondrial Bcl-2 expression [J].Clin Lymphoma Myeloma Leuk, 2012,12(2) : 138-143.
  • 4Bujak M, Frangogiannis NG.The role of TGF-beta signal- ing in myocardial infarction and cardiac remodeling [J]. Cardiovasc Res, 2007,74(2) : 184-195.
  • 5Fana XZ, Zhu HJ, Wu X,et al.Effects of doxycycline on cx43 distribution and cardiac arrhythmia susceptibility of rats after myocardial infarction [J].Iran J Pharm Res, 2014,13(2) :613-621.
  • 6Windecker S, Bax JJ, Myat A, et al.Future treatment strate- gies in ST-segment elevation myocardial infarction [J]. Lancet, 2013,382(9892) : 644-657.
  • 7Eapen ZJ,Tang WH, Felker GM,et al.Defining heart fail- ure end points in ST-segment elevation myocardial infarc- tion trials:integrating past experiences to chart a path for- ward[J].Cire Cardiovasc Qual Outcomes, 2012,5 (4) : 594- 600.
  • 8Heusch G,Libby P,Gersh B,et al.Cardiovascular remod- elling in coronary artery disease and heart failure [J]. Lancet, 2014,383 (9932) : 1933 - 1943.
  • 9Cohn JN,Ferrari R,Sharpe N.Cardiac remodeling-concepts and clinical implications:a consensus paper from an inter- national forum on cardiac remodeling.Behalf of an Inter- national Forum on Cardiac Remodeling [J].J Am Coil Cardiol, 2000,35 (3) : 569-582.
  • 10Kramer DG,Trikalinos TA,Kent DM,et al.Quantitative e- valuation of drug or device effects on ventricular remod- eling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach [J].J Am Coil Cardiol, 2010,56 (5) : 392-406.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部